DXCM DEADLINE: RLF, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2024, both dates inclusive (the “Class Period”), of the important October 21, 2024 lead plaintiff deadline.

SO WHAT: If you purchased DexCom securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the DexCom class action, go to https://rosenlegal.com/submit–form/?case_id=28133 or call Phillip Kim, Esq. at 866–767–3653 or email case@rosenlegal.com for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 21, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, on July 25, 2024, DexCom announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of DexCom’s salesforce; notably, that it was not truly equipped to execute on DexCom’s perceived growth potential. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the DexCom class action, go to https://rosenlegal.com/submit–form/?case_id=28133 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686–1060
        Toll Free: (866) 767–3653
        Fax: (212) 202–3827
        case@rosenlegal.com
        www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9258899)

2ONE Labs und Performance Plus Marketing, Verkäufer von 2ONE-Nikotinbeuteln, erheben Betrugsvorwürfe und fordern Schadensersatz im Markenrechtsverletzungfall in Bezug auf „Zone“ gegen Imperial Brands

LOS ANGELES, Oct. 08, 2024 (GLOBE NEWSWIRE) — In einem Fall, in dem einem der weltgrößten multinationalen Tabakkonzerne Betrug vorgeworfen wird, haben 2ONE Labs und Performance Plus Marketing sowohl eine Klage wegen Markenrechtsverletzung als auch eine einstweilige Verfügung gegen die Nikotinbeutelmarke der Imperial Brands–Tochtergesellschaft Zone eingereicht.

In der Klage wird behauptet, dass die Zone–Produkte von Imperial die Marke 2ONE® für tabakfreie Nikotinbeutel verletzen und dass die Verletzung vorsätzlich ist. Neben der Verurteilung zum Schadensersatz beantragt 2ONE® auch die Löschung der Marke Zone von Imperial.

Die Marke 2ONE® wurde in den letzten fünf Jahren kontinuierlich vermarktet und an erwachsene Verbraucher in Tausenden von Lebensmittelketten und unabhängigen Geschäften in den USA verkauft. Trotzdem brachte Imperial Brands im Jahr 2024 eine Produktlinie unter dem verwirrend ähnlichen Markennamen „Zone“ auf den Markt,

In der Klage wird Imperial Brands vorgeworfen, falsche Angaben gemacht zu haben, indem sie eine wesentlich frühere Benutzung ihrer Marke im Handel behaupteten, als tatsächlich stattgefunden hatte. In der Klage wird ferner behauptet, die falschen Angaben hätten es Zone ermöglicht, ein betrügerisches Markenzeichen zu erhalten.

„Wir haben seit der Einführung der Marke Zone durch Imperial im Jahr 2024 zahlreiche Fälle von Verwechslungen durch Verbraucher erlebt, und wir haben die Absicht, diese Art von eklatanten Verstößen energisch zu bekämpfen, ganz gleich, wie groß das Unternehmen ist“, so Vincent Schuman, Gründer und Partner von 2ONE Labs.

Die Kläger verlangen die Löschung der Marke der Beklagten sowie sämtliche Gewinne und Strafschadensersatz. Der Fall (Nummer 2:24–cv–08124) ist vor dem US–Bezirksgericht für den Central District of California anhängig und trägt den Titel 2ONE Labs, Inc. und Performance Plus Marketing, Inc. gegen ITG Brands, LLC und Imperial Tobacco Limited.

Über 2ONE Labs: 2ONE Labs wurde von den Pionieren im Bereich des synthetischen Nikotins TFN® in den USA gegründet und ist einer der wichtigsten Innovatoren im Bereich der hochwertigen Nikotinbeutel für erwachsene Verbraucher.

Medienanfragen: press@21pouches.com


GLOBENEWSWIRE (Distribution ID 9253405)

2ONE Labs et Performance Plus Marketing, vendeurs des sachets de nicotine 2ONE, dénoncent une fraude et réclament des dommages-intérêts dans le cadre d’une affaire de contrefaçon à l’encontre d’Imperial Brands pour la marque « Zone »

LOS ANGELES, 08 oct. 2024 (GLOBE NEWSWIRE) — Dans une affaire de dénonciation de fraude perpétrée par l’une des plus grandes multinationales de l’industrie du tabac au monde, 2ONE Labs et Performance Plus Marketing ont engagé des poursuites pour contrefaçon de marque, et demandé une injonction préliminaire contre la marque de sachets de nicotine Zone, filiale d’Imperial Brands.

Selon le contenu de la plainte, les produits Zone d’Imperial seraient une contrefaçon de la marque de sachets de nicotine sans tabac 2ONE® et cette contrefaçon serait délibérée. En plus d’exiger des dommages–intérêts, 2ONE® demande également l’arrêt de la marque Zone d’Imperial.

Les produits de la marque 2ONE® sont commercialisés et vendus sans interruption depuis cinq ans aux consommateurs adultes dans des milliers de chaînes de supérettes, d’épiceries indépendantes et de bureaux de tabac aux États–Unis. Pourtant, en 2024, Imperial Brands a lancé une gamme de produits sous le nom de marque « Zone » dont la similitude prête à confusion.

Selon le contenu de la plainte, Imperial Brands aurait émis de fausses déclarations, en affirmant que sa marque était utilisée dans le commerce bien plus tôt qu’en réalité. En outre, ces fausses déclarations auraient permis à Zone d’obtenir une marque de nature frauduleuse.

« Nous avons dû faire face à de nombreux cas de confusion de la part des consommateurs depuis qu’Imperial a lancé sa marque Zone, en 2024, et nous avons l’intention de lutter avec fermeté contre ce type de contrefaçon manifeste, quelle que soit l’importance de l’entreprise à l’origine du méfait », a déclaré Vincent Schuman, fondateur et associé de 2ONE Labs.

Les plaignants demandent l’arrêt de la marque des défendeurs, ainsi que tous les bénéfices et des dommages–intérêts à caractère punitif. L’affaire (n° 2:24–cv–08124) est portée devant le tribunal du district central de Californie sous le nom 2ONE Labs, Inc. et Performance Plus Marketing, Inc. versus ITG Brands, LLC et Imperial Tobacco Limited.

À propos de 2ONE Labs : fondé par les pionniers de la nicotine synthétique TFN® aux États–Unis, 2ONE Labs a joué un rôle novateur majeur, en proposant aux consommateurs adultes des sachets de nicotine de haute qualité.

Demandes médias : press@21pouches.com


GLOBENEWSWIRE (Distribution ID 9253405)

2ONE Labs e Performance Plus Marketing, vendedores de nicotina em saquinhos 2ONE, alegam fraude e buscam reparação de danos contra a Imperial Brands em um caso de violação da marca registrada “Zone”

LOS ANGELES, Oct. 08, 2024 (GLOBE NEWSWIRE) — Em um caso de alegação de fraude cometida por uma das maiores empresas multinacionais de produção de tabaco do mundo, a 2ONE Labs e a Performance Plus Marketing entraram com um processo de violação de marca registrada e um pedido de liminar contra uma subsidiária da Imperial Brands, a marca de saquinhos de nicotina Zone.

O processo alega que os produtos Zone da Imperial infringem a marca de saquinhos de nicotina sem tabaco 2ONE® e que a violação é intencional. Além de buscar indenização por danos, a 2ONE® também deseja o cancelamento da marca Zone da Imperial Brands.

A marca 2ONE® tem sido continuamente comercializada e vendida para consumidores adultos através de milhares de redes de conveniência e mercearias independentes e tabacarias dos EUA nos últimos cinco anos. Apesar disso, em 2024 a Imperial Brands lançou uma linha de produtos estampando a marca “Zone”, confusamente semelhante.

O processo alega que a Imperial Brands fez declarações falsas ao alegar um uso de sua marca no comércio muito antes deste fato. A ação alega ainda que as declarações falsas permitiram que a Zone recebesse uma marca fraudulenta.

“Temos presenciado vários casos de confusão por parte dos consumidores desde que a Imperial lançou a sua marca Zone, em 2024. Nossa intenção é combater energicamente este tipo de infração flagrante, independentemente do tamanho da intimidação corporativa que isso gere”, declarou o fundador e sócio da 2ONE Labs, Vincent Schuman.

Os autores da ação buscam o cancelamento da marca dos acusados, além de todos os lucros e indenizações punitivas pertinentes. O caso (número 2:24–cv–08124) está perante o Tribunal Distrital dos EUA para o Distrito Central da Califórnia, com a seguinte denominação: 2ONE Labs, Inc., e Performance Plus Marketing, Inc. vs. ITG Brands, LLC e Imperial Tobacco Limited.

Sobre a 2ONE Labs: fundada pelos pioneiros da nicotina sintética TFN® nos EUA, a 2ONE Labs tem sido uma importante inovadora ao oferecer aos consumidores adultos saquinhos de nicotina de alta qualidade.

Perguntas da mídia: press@21pouches.com


GLOBENEWSWIRE (Distribution ID 9253405)

2ONE Labs und Performance Plus Marketing, Verkäufer von 2ONE-Nikotinbeuteln, erheben Betrugsvorwürfe und fordern Schadensersatz im Markenrechtsverletzungfall in Bezug auf „Zone“ gegen Imperial Brands

LOS ANGELES, Oct. 08, 2024 (GLOBE NEWSWIRE) — In einem Fall, in dem einem der weltgrößten multinationalen Tabakkonzerne Betrug vorgeworfen wird, haben 2ONE Labs und Performance Plus Marketing sowohl eine Klage wegen Markenrechtsverletzung als auch eine einstweilige Verfügung gegen die Nikotinbeutelmarke der Imperial Brands–Tochtergesellschaft Zone eingereicht.

In der Klage wird behauptet, dass die Zone–Produkte von Imperial die Marke 2ONE® für tabakfreie Nikotinbeutel verletzen und dass die Verletzung vorsätzlich ist. Neben der Verurteilung zum Schadensersatz beantragt 2ONE® auch die Löschung der Marke Zone von Imperial.

Die Marke 2ONE® wurde in den letzten fünf Jahren kontinuierlich vermarktet und an erwachsene Verbraucher in Tausenden von Lebensmittelketten und unabhängigen Geschäften in den USA verkauft. Trotzdem brachte Imperial Brands im Jahr 2024 eine Produktlinie unter dem verwirrend ähnlichen Markennamen „Zone“ auf den Markt,

In der Klage wird Imperial Brands vorgeworfen, falsche Angaben gemacht zu haben, indem sie eine wesentlich frühere Benutzung ihrer Marke im Handel behaupteten, als tatsächlich stattgefunden hatte. In der Klage wird ferner behauptet, die falschen Angaben hätten es Zone ermöglicht, ein betrügerisches Markenzeichen zu erhalten.

„Wir haben seit der Einführung der Marke Zone durch Imperial im Jahr 2024 zahlreiche Fälle von Verwechslungen durch Verbraucher erlebt, und wir haben die Absicht, diese Art von eklatanten Verstößen energisch zu bekämpfen, ganz gleich, wie groß das Unternehmen ist“, so Vincent Schuman, Gründer und Partner von 2ONE Labs.

Die Kläger verlangen die Löschung der Marke der Beklagten sowie sämtliche Gewinne und Strafschadensersatz. Der Fall (Nummer 2:24–cv–08124) ist vor dem US–Bezirksgericht für den Central District of California anhängig und trägt den Titel 2ONE Labs, Inc. und Performance Plus Marketing, Inc. gegen ITG Brands, LLC und Imperial Tobacco Limited.

Über 2ONE Labs: 2ONE Labs wurde von den Pionieren im Bereich des synthetischen Nikotins TFN® in den USA gegründet und ist einer der wichtigsten Innovatoren im Bereich der hochwertigen Nikotinbeutel für erwachsene Verbraucher.

Medienanfragen: press@21pouches.com


GLOBENEWSWIRE (Distribution ID 9253404)

2ONE Labs et Performance Plus Marketing, vendeurs des sachets de nicotine 2ONE, dénoncent une fraude et réclament des dommages-intérêts dans le cadre d’une affaire de contrefaçon à l’encontre d’Imperial Brands pour la marque « Zone »

LOS ANGELES, 08 oct. 2024 (GLOBE NEWSWIRE) — Dans une affaire de dénonciation de fraude perpétrée par l’une des plus grandes multinationales de l’industrie du tabac au monde, 2ONE Labs et Performance Plus Marketing ont engagé des poursuites pour contrefaçon de marque, et demandé une injonction préliminaire contre la marque de sachets de nicotine Zone, filiale d’Imperial Brands.

Selon le contenu de la plainte, les produits Zone d’Imperial seraient une contrefaçon de la marque de sachets de nicotine sans tabac 2ONE® et cette contrefaçon serait délibérée. En plus d’exiger des dommages–intérêts, 2ONE® demande également l’arrêt de la marque Zone d’Imperial.

Les produits de la marque 2ONE® sont commercialisés et vendus sans interruption depuis cinq ans aux consommateurs adultes dans des milliers de chaînes de supérettes, d’épiceries indépendantes et de bureaux de tabac aux États–Unis. Pourtant, en 2024, Imperial Brands a lancé une gamme de produits sous le nom de marque « Zone » dont la similitude prête à confusion.

Selon le contenu de la plainte, Imperial Brands aurait émis de fausses déclarations, en affirmant que sa marque était utilisée dans le commerce bien plus tôt qu’en réalité. En outre, ces fausses déclarations auraient permis à Zone d’obtenir une marque de nature frauduleuse.

« Nous avons dû faire face à de nombreux cas de confusion de la part des consommateurs depuis qu’Imperial a lancé sa marque Zone, en 2024, et nous avons l’intention de lutter avec fermeté contre ce type de contrefaçon manifeste, quelle que soit l’importance de l’entreprise à l’origine du méfait », a déclaré Vincent Schuman, fondateur et associé de 2ONE Labs.

Les plaignants demandent l’arrêt de la marque des défendeurs, ainsi que tous les bénéfices et des dommages–intérêts à caractère punitif. L’affaire (n° 2:24–cv–08124) est portée devant le tribunal du district central de Californie sous le nom 2ONE Labs, Inc. et Performance Plus Marketing, Inc. versus ITG Brands, LLC et Imperial Tobacco Limited.

À propos de 2ONE Labs : fondé par les pionniers de la nicotine synthétique TFN® aux États–Unis, 2ONE Labs a joué un rôle novateur majeur, en proposant aux consommateurs adultes des sachets de nicotine de haute qualité.

Demandes médias : press@21pouches.com


GLOBENEWSWIRE (Distribution ID 9253404)

2ONE Labs e Performance Plus Marketing, vendedores de nicotina em saquinhos 2ONE, alegam fraude e buscam reparação de danos contra a Imperial Brands em um caso de violação da marca registrada “Zone”

LOS ANGELES, Oct. 08, 2024 (GLOBE NEWSWIRE) — Em um caso de alegação de fraude cometida por uma das maiores empresas multinacionais de produção de tabaco do mundo, a 2ONE Labs e a Performance Plus Marketing entraram com um processo de violação de marca registrada e um pedido de liminar contra uma subsidiária da Imperial Brands, a marca de saquinhos de nicotina Zone.

O processo alega que os produtos Zone da Imperial infringem a marca de saquinhos de nicotina sem tabaco 2ONE® e que a violação é intencional. Além de buscar indenização por danos, a 2ONE® também deseja o cancelamento da marca Zone da Imperial Brands.

A marca 2ONE® tem sido continuamente comercializada e vendida para consumidores adultos através de milhares de redes de conveniência e mercearias independentes e tabacarias dos EUA nos últimos cinco anos. Apesar disso, em 2024 a Imperial Brands lançou uma linha de produtos estampando a marca “Zone”, confusamente semelhante.

O processo alega que a Imperial Brands fez declarações falsas ao alegar um uso de sua marca no comércio muito antes deste fato. A ação alega ainda que as declarações falsas permitiram que a Zone recebesse uma marca fraudulenta.

“Temos presenciado vários casos de confusão por parte dos consumidores desde que a Imperial lançou a sua marca Zone, em 2024. Nossa intenção é combater energicamente este tipo de infração flagrante, independentemente do tamanho da intimidação corporativa que isso gere”, declarou o fundador e sócio da 2ONE Labs, Vincent Schuman.

Os autores da ação buscam o cancelamento da marca dos acusados, além de todos os lucros e indenizações punitivas pertinentes. O caso (número 2:24–cv–08124) está perante o Tribunal Distrital dos EUA para o Distrito Central da Califórnia, com a seguinte denominação: 2ONE Labs, Inc., e Performance Plus Marketing, Inc. vs. ITG Brands, LLC e Imperial Tobacco Limited.

Sobre a 2ONE Labs: fundada pelos pioneiros da nicotina sintética TFN® nos EUA, a 2ONE Labs tem sido uma importante inovadora ao oferecer aos consumidores adultos saquinhos de nicotina de alta qualidade.

Perguntas da mídia: press@21pouches.com


GLOBENEWSWIRE (Distribution ID 9253404)

2ONE Labs and Performance Plus Marketing, sellers of 2ONE Nicotine Pouches, Allege Fraud and Seek Damages in 'Zone' Trademark Infringement Case Against Imperial Brands

LOS ANGELES, Oct. 07, 2024 (GLOBE NEWSWIRE) — In a case alleging fraud by one of the world’s largest multinational tobacco companies, 2ONE Labs and Performance Plus Marketing have filed both a trademark infringement lawsuit and a preliminary injunction against Imperial Brand subsidiaries Zone nicotine pouch mark.

The suit alleges that Imperial’s Zone products infringe the 2ONE® tobacco–free nicotine pouch brand and that the infringement is willful. In addition to seeking an award for damages, 2ONE® is also seeking cancellation of Imperial’s Zone mark.

The 2ONE® brand has been continuously marketed and sold to adult consumers through thousands of convenience chain and independent grocery and smoke shop stores across the USA for the last five years. Despite this, in 2024 Imperial Brands launched a line of products under the confusingly similar “Zone” brand name,

The suit alleges Imperial Brands made false statements by claiming a significantly earlier use of their mark in commerce than had occurred. The suit further alleges the false statements allowed Zone to be granted a fraudulent mark.

“We have experienced numerous instances of consumer confusion since Imperial launched its Zone brand in 2024 and we intend to vigorously fight this type of blatant infringement, no matter how big the corporate bully,” said 2ONE Labs founder and partner Vincent Schuman.

The plaintiffs seek cancellation of the defendants’ mark, plus all profits and punitive damages. The case (number 2:24–cv–08124) is before the US District Court for the Central District of California, and is styled 2ONE Labs, Inc., and Performance Plus Marketing, Inc. vs. ITG Brands, LLC and Imperial Tobacco Limited.

About 2ONE Labs: Founded by the pioneers of TFN® synthetic nicotine in the USA, 2ONE labs has been a key innovator in offering adult consumers high quality nicotine pouches.

Media Inquiries: press@21pouches.com


GLOBENEWSWIRE (Distribution ID 9252620)

FIVE DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Five Below, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 30 Deadline in Securities Class Action – FIVE

NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Five Below, Inc. (NASDAQ: FIVE) between March 20, 2024 and July 16, 2024, both dates inclusive (the “Class Period”), of the important September 30, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Five Below securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Five Below class action, go to https://rosenlegal.com/submit–form/?case_id=27613 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 30, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants provided investors with false and/or materially misleading information about Five Below’s financial strength and operations, including its outlook for the first quarter and full year 2024. This information included Five Below’s statement that net sales are expected to be in the range of $826 million to $846 million based on opening approximately 55 to 60 new stores in the first quarter. Further, Five Below claimed that net sales for the full year are expected to be in the range of $3.97 billion to $4.07 billion based on opening between 225 and 235 new stores. Investors discovered that these statements were false and/or materially misleading when, on June 5, 2024, Five Below announced disappointing first quarter 2024 sales result and cut its full year 2024 guidance stating, “Net sales are expected to be in the range of $3.79 billion to $3.87 billion based on opening approximately 230 new stores.” At the same time, Five Below claimed that for the second quarter, “Net sales are expected to be in the range of $830 million to $850 million based on opening approximately 60 new stores.” When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Five Below class action, go to https://rosenlegal.com/submit–form/?case_id=27613 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686–1060
        Toll Free: (866) 767–3653
        Fax: (212) 202–3827
        case@rosenlegal.com
        www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9237785)

XPEL DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages XPEL, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 7 Deadline in Securities Class Action – XPEL

NEW YORK, Sept. 29, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of XPEL, Inc. (NASDAQ: XPEL) between November 8, 2023 and May 2, 2024, both dates inclusive (the “Class Period”), of the important October 7, 2024 lead plaintiff deadline.

SO WHAT: If you purchased XPEL securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the XPEL class action, go to https://rosenlegal.com/submit–form/?case_id=20245 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 7, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million or investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) XPEL’s competitors were siphoning an increasingly large segment of the market; (2) as a result, XPEL’s revenue growth became increasingly dependent upon existing customers and partners; (3) as a result, XPEL’s revenue growth for 2023 and 2024 dwindled; and (4) as a result, defendants’ positive statements about XPEL’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the XPEL class action, go to https://rosenlegal.com/submit–form/?case_id=20245 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686–1060
        Toll Free: (866) 767–3653
        Fax: (212) 202–3827
        case@rosenlegal.com
        www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9237818)